AUG 10, 2026 · PHASE 2/3 TRIAL
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
ClinicalTrials.gov
This is a clinical trial registry record describing a planned Phase 2/3 study with no results posted; enrollment is ongoing and primary outcomes have not yet been reported.
Reported
Planned enrollment342
Study phasePhase 2/Phase 3
Primary efficacy endpoint (Base P…Change from baseline to Week 16 in NT-proBNP